Vaginal and Rectal Clostridial Carriage Among Women of Reproductive Age in the United States
NCT01283828 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4977
Last updated 2013-10-07
Summary
This primary goals of this study are to: estimate the prevalence of Clostridium sordellii and Clostridium perfringens carriage in the rectum and/or vagina among women of reproductive age; estimate duration of carriage of the two clostridium species; and estimate the incidence of carriage at 2 weeks after a negative test.
Conditions
- Clostridium Sordellii
- Clostridium Perfringens
Sponsors & Collaborators
-
Gynuity Health Projects
lead OTHER
Principal Investigators
-
Beverly Winikoff, M.D., M.P.H. · Gynuity Health Projects
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2013-04-30
- Completion
- 2013-04-30
Countries
- United States
Study Locations
More Related Trials
-
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
NCT04259931 ·Status: UNKNOWN
-
Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis
NCT03099408 ·Status: COMPLETED ·Phase: PHASE4
-
Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection
NCT02086916 ·Status: COMPLETED
-
C.Difficile Observational Study
NCT06277999 ·Status: COMPLETED
-
Clostridioides Difficile Controlled Human Infection Model
NCT06702345 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Value of Bacterial Loads by Real Time PCR in Predicting Recurrence of Abnormal Vaginal Flora After Oral Metronidazole Therapy
NCT01287728 ·Status: COMPLETED ·Phase: PHASE3
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection
NCT05320068 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
NCT04679324 ·Status: WITHDRAWN
-
Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea
NCT04567134 ·Status: UNKNOWN
-
Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study
NCT03918629 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis
NCT00324142 ·Status: WITHDRAWN ·Phase: PHASE2
-
Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin
NCT07221708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Screening to Prophylax Against Clostridium Difficile Infection -
NCT02996487 ·Status: COMPLETED ·Phase: PHASE4
-
Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
NCT02237859 ·Status: UNKNOWN ·Phase: PHASE4
-
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection
NCT03988855 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.
NCT02106338 ·Status: COMPLETED ·Phase: PHASE1
-
Clostridioides Difficile Colonisation
NCT05693077 ·Status: RECRUITING ·Phase: PHASE1
-
PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"
NCT03187457 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients
NCT02200328 ·Status: TERMINATED ·Phase: PHASE4
-
Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics
NCT03466502 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)
NCT02835118 ·Status: COMPLETED ·Phase: PHASE1
-
To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults
NCT05805826 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Oral Vancomycin for Preventing Clostridium Difficile Recurrence
NCT03200093 ·Status: TERMINATED ·Phase: PHASE4